The pharmaceutical landscape is experiencing a change with the arrival of GLP-1 delivery devices. These innovative formulations offer a possible approach to providing glucagon-like peptide-1 medication for individuals managing hyperglycemia. Instead of injections , a easy-to-use patch applied to